Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of products and services for drug discovery research, has acquired privately-held Cambridge Research & Instrumentation, Inc. (CRi) pursuant to the terms of a merger agreement announced on December 9, 2010.
